{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T04:43:03Z","timestamp":1766983383002,"version":"3.41.2"},"reference-count":37,"publisher":"Pharmaceutical Society of Japan","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2025,7,16]]},"DOI":"10.1248\/bpb.b25-00312","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T22:07:46Z","timestamp":1752617266000},"page":"1031-1039","source":"Crossref","is-referenced-by-count":1,"title":["Second-Generation H&lt;sub&gt;1&lt;\/sub&gt;-Receptor Antagonists, Mequitazine, Azelastine and Desloratadine Activate Caspase-8, Caspase-3, and Gasdermin E and Induce Cell Death Showing Pyroptotic-Like Features in Macrophages at Excessively High Concentrations"],"prefix":"10.1248","volume":"48","author":[{"given":"Akane","family":"Ito","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Pharmacology, College of Pharmaceutical Sciences, Matsuyama University, 4\u20132 Bunkyo-cho, Matsuyama, Ehime 790\u20138578, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Sawamoto","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Pharmacology, College of Pharmaceutical Sciences, Matsuyama University, 4\u20132 Bunkyo-cho, Matsuyama, Ehime 790\u20138578, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Okuyama","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Pharmacology, College of Pharmaceutical Sciences, Matsuyama University, 4\u20132 Bunkyo-cho, Matsuyama, Ehime 790\u20138578, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsunari","family":"Nakajima","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Pharmacology, College of Pharmaceutical Sciences, Matsuyama University, 4\u20132 Bunkyo-cho, Matsuyama, Ehime 790\u20138578, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Wang D, Guo Q, Wu Z, Li M, He B, Du Y, Zhang K, Tao Y. Molecular mechanism of antihistamines recognition and regulation of the histamine H<sub>1<\/sub> receptor. <i>Nat. Commun.<\/i>, <b>15<\/b>, 84 (2024).","DOI":"10.1038\/s41467-023-44477-4"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Jutel M, Akdis M, Akdis CA. Histamine, histamine receptors and their role in immune pathology. <i>Clin. Exp. Allergy<\/i>, <b>39<\/b>, 1786\u20131800 (2009).","DOI":"10.1111\/j.1365-2222.2009.03374.x"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Fink SL, Cookson BT. Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells. <i>Infect. Immun.<\/i>, <b>73<\/b>, 1907\u20131916 (2005).","DOI":"10.1128\/IAI.73.4.1907-1916.2005"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Shi J, Gao W, Shao F. Pyroptosis: Gasdermin-mediated programmed necrotic cell death. <i>Trends Biochem. Sci.<\/i>, <b>42<\/b>, 245\u2013254 (2017).","DOI":"10.1016\/j.tibs.2016.10.004"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Martin SJ, Henry CM, Cullen SP. A perspective on mammalian caspases as positive and negative regulators of inflammation. <i>Mol. Cell<\/i>, <b>46<\/b>, 387\u2013397 (2012).","DOI":"10.1016\/j.molcel.2012.04.026"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Bertheloot D, Latz E, Franklin BS. Necroptosis, pyroptosis and apoptosis: an intricate game of cell death. <i>Cell. Mol. Immunol.<\/i>, <b>18<\/b>, 1106\u20131121 (2021).","DOI":"10.1038\/s41423-020-00630-3"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Tsuchiya K, Hosojima S, Hara H, Kushiyama H, Mahib MR, Kinoshita T, Suda T. Gasdermin D mediates the maturation and release of IL-1<i>\u03b1<\/i> downstream of inflammasomes. <i>Cell Rep.<\/i>, <b>34<\/b>, 108887 (2021).","DOI":"10.1016\/j.celrep.2021.108887"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Chao YY, Puhach A, Frieser D, Arunkumar M, Lehner L, Seeholzer T, Garcia-Lopez A, van der Wal M, Fibi-Smetana S, Dietschmann A, Sommermann T, \u0106ikovi\u0107 T, Taher L, Gresnigt MS, Vastert SJ, van Wijk F, Panagiotou G, Krappmann D, Gro\u00df O, Zielinski CE. Human T<sub>H<\/sub>17 cells engage gasdermin E pores to release IL-1apha on NLRP3 inflammasome activation. <i>Nat. Immunol.<\/i>, <b>24<\/b>, 295\u2013308 (2023).","DOI":"10.1038\/s41590-022-01386-w"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Tsuchiya K, Nakajima S, Hosojima S, Thi Nguyen D, Hattori T, Manh Le T, Hori O, Mahib MR, Yamaguchi Y, Miura M, Kinoshita T, Kushiyama H, Sakurai M, Shiroishi T, Suda T. Caspase-1 initiates apoptosis in the absence of gasdermin D. <i>Nat. Commun.<\/i>, <b>10<\/b>, 2091 (2019).","DOI":"10.1038\/s41467-019-09753-2"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Liu S, Perez P, Sun X, Chen K, Fatirkhorani R, Mammadova J, Wang Z. MLKL polymerization-induced lysosomal membrane permeabilization promotes necroptosis. <i>Cell Death Differ.<\/i>, <b>31<\/b>, 40\u201352 (2024).","DOI":"10.1038\/s41418-023-01237-7"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Zhan C, Huang M, Yang X, Hou J. MLKL: Functions beyond serving as the Executioner of Necroptosis. <i>Theranostics<\/i>, <b>11<\/b>, 4759\u20134769 (2021).","DOI":"10.7150\/thno.54072"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Ueda H, Fujita R. Cell death mode switch from necrosis to apoptosis in brain. <i>Biol. Pharm. Bull.<\/i>, <b>27<\/b>, 950\u2013955 (2004).","DOI":"10.1248\/bpb.27.950"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Han J, Zhong CQ, Zhang DW. Programmed necrosis: backup to and competitor with apoptosis in the immune system. <i>Nat. Immunol.<\/i>, <b>12<\/b>, 1143\u20131149 (2011).","DOI":"10.1038\/ni.2159"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Chan FK, Luz NF, Moriwaki K. Programmed necrosis in the cross talk of cell death and inflammation. <i>Annu. Rev. Immunol.<\/i>, <b>33<\/b>, 79\u2013106 (2015).","DOI":"10.1146\/annurev-immunol-032414-112248"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Latz E, Xiao TS, Stutz A. Activation and regulation of the inflammasomes. <i>Nat. Rev. Immunol.<\/i>, <b>13<\/b>, 397\u2013411 (2013).","DOI":"10.1038\/nri3452"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Fritsch M, G\u00fcnther SD, Schwarzer R, Albert MC, Schorn F, Werthenbach JP, Schiffmann LM, Stair N, Stocks H, Seeger JM, Lamkanfi M, Kr\u00f6nke M, Pasparakis M, Kashkar H. Caspase-8 is the molecular switch for apoptosis, necroptosis and pyroptosis. <i>Nature<\/i>, <b>575<\/b>, 683\u2013687 (2019).","DOI":"10.1038\/s41586-019-1770-6"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Rogers C, Fernandes-Alnemri T, Mayes L, Alnemri D, Cingolani G, Alnemri ES. Cleavage of DFNA5 by caspase-3 during apoptosis mediates progression to secondary necrotic\/pyroptotic cell death. <i>Nat. Commun.<\/i>, <b>8<\/b>, 14128 (2017).","DOI":"10.1038\/ncomms14128"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Wang Y, Gao W, Shi X, Ding J, Liu W, He H, Wang K, Shao F. Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin. <i>Nature<\/i>, <b>547<\/b>, 99\u2013103 (2017).","DOI":"10.1038\/nature22393"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Aizawa E, Karasawa T, Watanabe S, Komada T, Kimura H, Kamata R, Ito H, Hishida E, Yamada N, Kasahara T, Mori Y, Takahashi M. GSDME-dependent incomplete pyroptosis permits selective IL-1alpha release under caspase-1 inhibition. <i>iScience<\/i>, <b>23<\/b>, 101070 (2020).","DOI":"10.1016\/j.isci.2020.101070"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Wynn TA, Chawla A, Pollard JW. Macrophage biology in development, homeostasis and disease. <i>Nature<\/i>, <b>496<\/b>, 445\u2013455 (2013).","DOI":"10.1038\/nature12034"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Satoh T, Kidoya H, Naito H, Yamamoto M, Takemura N, Nakagawa K, Yoshioka Y, Morii E, Takakura N, Takeuchi O, Akira S. Critical role of Trib1 in differentiation of tissue-resident M2-like macrophages. <i>Nature<\/i>, <b>495<\/b>, 524\u2013528 (2013).","DOI":"10.1038\/nature11930"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Li Z, Liu W, Fu J, Cheng S, Xu Y, Wang Z, Liu X, Shi X, Liu Y, Qi X, Liu X, Ding J, Shao F. Shigella evades pyroptosis by arginine ADP-riboxanation of caspase-11. <i>Nature<\/i>, <b>599<\/b>, 290\u2013295 (2021).","DOI":"10.1038\/s41586-021-04020-1"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Okabe Y, Medzhitov R. Tissue-specific signals control reversible program of localization and functional polarization of macrophages. <i>Cell<\/i>, <b>157<\/b>, 832\u2013844 (2014).","DOI":"10.1016\/j.cell.2014.04.016"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Ishikawa S, Sawamoto A, Okuyama S, Nakajima M. T-cell activation-inhibitory assay to screen caloric restriction mimetics drugs for drug repositioning. <i>Biol. Pharm. Bull.<\/i>, <b>44<\/b>, 550\u2013556 (2021).","DOI":"10.1248\/bpb.b20-00889"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Jorgensen I, Miao EA. Pyroptotic cell death defends against intracellular pathogens. <i>Immunol. Rev.<\/i>, <b>265<\/b>, 130\u2013142 (2015).","DOI":"10.1111\/imr.12287"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Chen X, He WT, Hu L, Li J, Fang Y, Wang X, Xu X, Wang Z, Huang K, Han J. Pyroptosis is driven by non-selective gasdermin-D pore and its morphology is different from MLKL channel-mediated necroptosis. <i>Cell Res.<\/i>, <b>26<\/b>, 1007\u20131020 (2016).","DOI":"10.1038\/cr.2016.100"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Anthes JC, Gilchrest H, Richard C, Eckel S, Hesk D, West RE Jr, Williams SM, Greenfeder S, Billah M, Kreutner W, Egan RE. Biochemical characterization of desloratadine, a potent antagonist of the human histamine H<sub>1<\/sub> receptor. <i>Eur. J. Pharmacol.<\/i>, <b>449<\/b>, 229\u2013237 (2002).","DOI":"10.1016\/S0014-2999(02)02049-6"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Kubo N, Shirakawa O, Kuno T, Tanaka C. Antimuscarinic effects of antihistamines: quantitative evaluation by receptor-binding assay. <i>Jpn. J. Pharmacol.<\/i>, <b>43<\/b>, 277\u2013282 (1987).","DOI":"10.1016\/S0021-5198(19)43508-7"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Miyawaki S, Sawamoto A, Okuyama S, Nakajima M. Sulconazole induces pyroptosis promoted by interferon-<i>\u03b3<\/i> in monocyte\/macrophage lineage cells. <i>J. Pharmacol. Sci.<\/i>, <b>154<\/b>, 166\u2013174 (2024).","DOI":"10.1016\/j.jphs.2024.01.006"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Yu J, Li S, Qi J, Chen Z, Wu Y, Guo J, Wang K, Sun X, Zheng J. Cleavage of GSDME by caspase-3 determines lobaplatin-induced pyroptosis in colon cancer cells. <i>Cell Death Dis.<\/i>, <b>10<\/b>, 193 (2019).","DOI":"10.1038\/s41419-019-1441-4"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Wei Y, Lan B, Zheng T, Yang L, Zhang X, Cheng L, Tuerhongjiang G, Yuan Z, Wu Y. GSDME-mediated pyroptosis promotes the progression and associated inflammation of atherosclerosis. <i>Nat. Commun.<\/i>, <b>14<\/b>, 929 (2023).","DOI":"10.1038\/s41467-023-36614-w"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Ma F, Ghimire L, Ren Q, Fan Y, Chen T, Balasubramanian A, Hsu A, Liu F, Yu H, Xie X, Xu R, Luo HR. Gasdermin E dictates inflammatory responses by controlling the mode of neutrophil death. <i>Nat. Commun.<\/i>, <b>15<\/b>, 386 (2024).","DOI":"10.1038\/s41467-023-44669-y"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Vandenabeele P, Vanden Berghe T, Festjens N. Caspase inhibitors promote alternative cell death pathways. <i>Sci. STKE<\/i>, <b>2006<\/b>, pe44 (2006).","DOI":"10.1126\/stke.3582006pe44"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Los M, Mozoluk M, Ferrari D, Stepczynska A, Stroh C, Renz A, Herceg Z, Wang ZQ, Schulze-Osthoff K. Activation and caspase-mediated inhibition of PARP: a molecular switch between fibroblast necrosis and apoptosis in death receptor signaling. <i>Mol. Biol. Cell<\/i>, <b>13<\/b>, 978\u2013988 (2002).","DOI":"10.1091\/mbc.01-05-0272"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Prabhakaran K, Li L, Borowitz JL, Isom GE. Caspase inhibition switches the mode of cell death induced by cyanide by enhancing reactive oxygen species generation and PARP-1 activation. <i>Toxicol. Appl. Pharmacol.<\/i>, <b>195<\/b>, 194\u2013202 (2004).","DOI":"10.1016\/j.taap.2003.11.012"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Lafont E, Milhas D, Teissi\u00e9 J, Therville N, Andrieu-Abadie N, Levade T, Benoist H, S\u00e9gui B. Caspase-10-dependent cell death in Fas\/CD95 signalling is not abrogated by caspase inhibitor zVAD-fmk. <i>PLoS One<\/i>, <b>5<\/b>, e13638 (2010).","DOI":"10.1371\/journal.pone.0013638"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Kalpaklioglu F, Baccioglu A. Efficacy and safety of H<sub>1<\/sub>-antihistamines: an update. <i>Antiinflamm. Antiallergy Agents Med. Chem.<\/i>, <b>11<\/b>, 230\u2013237 (2012).","DOI":"10.2174\/1871523011202030230"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/48\/7\/48_b25-00312\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T04:03:49Z","timestamp":1752897829000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/48\/7\/48_b25-00312\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,16]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b25-00312","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"type":"print","value":"0918-6158"},{"type":"electronic","value":"1347-5215"}],"subject":[],"published":{"date-parts":[[2025,7,16]]},"article-number":"b25-00312"}}